CCL4 and metabolic syndrome: Second, treatment with the CCL4 antibody could retard the elevation of blood sugar levels in db/db mice (a model simulating type 2 DM) and reduce the blood sugar levels in mice fed a high fat diet (a model simulating metabolic syndrome).